Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115323) titled 'Development and application of iron metabolism-based model for early warning of anti-tuberculosis drug-induced liver injury' on Dec. 24, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Chongqing Public Health Medical Center
Condition:
Anti-tuberculosis drug-induced liver injury
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2025-03-19
Target Sample Size: Observational group:470;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=266376
Published by HT Digital Content Services with permission from Hea...